
Randy R. Brutkiewicz, PhD
Professor of Microbiology & Immunology
- Phone
- (317) 274-7589
- Address
-
R2 302
950 W. Walnut St.
Indianapolis, IN - PubMed:
-
Bio
Randy R. Brutkiewicz earned his PhD degree from the University of Massachusetts Medical School and received postdoctoral training at the National Institutes of Health. He is a Professor of Microbiology and Immunology at Indiana University School of Medicine, with an NIH-funded laboratory studying innate immunity, immune evasion and signal transduction pathways in the context of neurodegenerative and other CNS disorders.
Key Publications
Selected Recent Publications
1. Wyatt-Johnson, S.K, Kersey, H.N., Codocedo, J.F., Newell, K.L., Landreth, G.E., Lamb, B.T., Oblak, A.L., Brutkiewicz, R.R. Control of the temporal development of Alzheimer’s disease pathology by the MR1/MAIT cell axis. J. Neuroinflammation 20:78, 2023. PMID: 36944969.
2. Shrinivasan, R., Wyatt-Johnson, S.K., Brutkiewicz, R.R. The MR1/MAIT cell axis in CNS diseases. Brain, Behavior, and Immunity 116:321-328, 2024. PMCID: PMC10842441.
3. Wyatt-Johnson, S.K., Afify, R., Brutkiewicz, R.R. The immune system in neurological diseases: What innate-like T cells have to say. J. Allergy Clin. Immunol. 153(4):913-923, 2024. PMCID: PMC10999338.
4. Afify, R., Lipsius, K., Wyatt-Johnson, S.K., Brutkiewicz, R.R. Myeloid Antigen-Presenting Cells in Neurodegenerative Diseases: A focus on Classical and Non-Classical MHC Molecules. Front. Neurosci. (Section Neurodegeneration), 18:1488382, 2024. PMCID: PMC11667120.
5. Wyatt-Johnson, S.K, Kersey, H.N., Brutkiewicz, R.R. Enrichment of liver MAIT cells in a mouse model of Alzheimer’s disease. J. Neuroimmunology 390:578332, 2024. PMID: 38537322.
6. Wyatt-Johnson, S.K., Ackley, S., Warren, J., Raj Priya, Wan, J., Liu, S., Brutkiewicz, R.R. The MR1/MAIT cell axis enhances dystrophic neurite development in Alzheimer’s disease. Alzheimer’s Dement 21(2):e14480, 2025. PMID: 39777865. PMCID: PMC11848147.
7. Ping, X., Xiong, W., Priya, Raj, Liu, J., Wyatt-Johnson, S.K.; Brutkiewicz, R.R., Jin, X. Blocking the innate immune CD1d/NKT cell axis prevents the development of cortical hyperexcitability and posttraumatic epilepsy. Epilepsia 66(6):2110-2123, 2025. PMCID: PMC12169402.
8. Brutkiewicz, R.R., Cao, W., Morgan, D., Souza Dos Reis, R., Suryadevara, V., Willette, A.A., Willette, S.A., Wyatt-Johnson, S.K., Duggan, M.R. What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? Trends in Neurosciences 16:S0166-2236(25)00104-3, 2025.
9. Wyatt-Johnson, S.K., Desai, J.M., Wireman, A., Eipers, P., Morrow, C., Vornhagen, J., Brutkiewicz, R.R. The MR1/MAIT cell axis impacts the gut-brain axis through both cognition and microbial community structure in 5XFAD mice. Alzheimer’s Dement 21(7):e70493, 2025. PMID: 40696831. PMCID: PMC12284323.
10. Chen, J., Han, X., Liu, Z., Zhou, C.Q., Hu, R., Tabassam, S., Wyatt-Johnson, S.K., Oblak, A.L., Brutkiewicz, R.R., Lin, M., Wang, N. Detecting Beta-Amyloid Plaque via Low Rank Based Orthogonal Projection and Spatial-spectrum Detector Using High-resolution Quantitative Susceptibility Mapping for Preclinical Studies. IEEE Transactions on Biomedical Engineering PP:10.1109/TBME.2025.3614233, 2025. PMID: 40991598.
| Year | Degree | Institution |
|---|---|---|
| 1994 | PhD | University of Massachusetts |
| 1981 | BS | Michigan State University |
Research Program
The Brutkiewicz Laboratory investigates how innate immune pathways contribute to neurological disease and seeks to identify novel immunological targets for therapeutic intervention. Our work is grounded in a long-standing interest in antigen presentation and unconventional T cell biology, with a current emphasis on neuroinflammation, Alzheimer's disease (AD), traumatic brain injury (TBI), and post-traumatic epilepsy.
Research Vision
The central premise of our research is that immune responses that normally protect the host can become maladaptive in the central nervous system, driving chronic inflammation and neurodegeneration. We aim to define the cellular and molecular mechanisms that connect antigen presentation pathways, innate-like T cells, glial activation, and neuronal dysfunction.
By integrating immunology, neuroscience, and translational disease models, we seek to identify immune pathways that can be therapeutically targeted to slow or prevent neurological disease progression.
Major Research Areas
MR1 and MAIT Cells in Alzheimer's Disease
Our laboratory has established that the major histocompatibility complex class I-related molecule MR1 and mucosal-associated invariant T (MAIT) cells contribute to Alzheimer's disease pathology. We demonstrated that disruption of the MR1/MAIT cell axis slows amyloid-β pathology and alters neuroinflammatory responses in mouse models of AD. We are currently investigating:
· How MAIT cells become activated during disease
· The cellular sources and identity of MR1-presented ligands in the brain
· Interactions between MAIT cells, microglia, astrocytes, and brain endothelial cells
· The contribution of peripheral immune organs, particularly the liver, to disease progression
· Therapeutic targeting of the MR1/MAIT pathway in Alzheimer's disease
Our long-term goal is to determine whether this immune axis represents a druggable pathway for neurodegenerative disorders.
Neuroinflammation and Glial Cell Biology
We study how astrocytes and microglia detect pathological signals and propagate inflammatory responses in the CNS. Current projects focus on:
· Mechanisms of microglial activation in Alzheimer's disease
· Astrocyte-mediated inflammatory signaling
· Antigen presentation within the CNS
· Crosstalk between innate and adaptive immune cells during neurodegeneration
These studies seek to define how resident brain cells shape disease progression and influence neuronal survival.
Immune Mechanisms of Traumatic Brain Injury and Epilepsy
Another area of investigation is the role of innate-like T cells in post-traumatic epilepsy. Using experimental models of TBI, we have shown that the CD1d/NKT cell axis plays a critical role in the development of cortical hyperexcitability and seizure susceptibility.
Current efforts seek to:
· Define immune mechanisms underlying epileptogenesis
· Identify neuroimmune biomarkers of disease progression
· Evaluate immune-targeted therapeutic strategies following brain injury
· Determine how antigen presentation pathways regulate neuroinflammation after trauma
These studies may provide a foundation for the development of preventive therapies for post-traumatic epilepsy.
Antigen Presentation and Unconventional T Cell Biology
Our laboratory has a long-standing interest in mechanisms regulating antigen presentation by CD1d and MR1 molecules and how these pathways influence innate immune responses.
Ongoing studies examine:
· Regulation of MR1 antigen presentation
· Cellular signaling pathways controlling unconventional antigen presentation
· Activation and function of MAIT and invariant NKT cells
· Immune evasion strategies used by pathogens and diseased tissues
These investigations provide fundamental insights into how innate-like T cells influence human disease.
Experimental Approaches
The laboratory employs a multidisciplinary approach that integrates:
· Transgenic and disease-model mice
· Flow cytometry and high-parameter immune profiling
· Single-cell transcriptomic analyses
· Human brain tissue studies
· Advanced imaging and microscopy
· Molecular and cellular immunology
· Neurobehavioral and neuropathological assessments
This combination of approaches enables mechanistic investigation from molecular pathways to whole-animal disease outcomes.
Liu J; Gallo RM; Duffy C; Brutkiewicz RR; Viral immunology 2016 Jun 21
Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR; Pathogens and disease 2016 Jun 12
Desc: Trustees' Teaching Award
Scope: University
Date: 2010-05-01